$2.3 million NIH Grant Aims to Help Improve Diversity in Science and Health Care
Through a recent five-year, $2.3 million grant from the National Institutes of Health (NIH), University of Kentucky faculty Don Frazier and Brett Spear will partner with faculty from qualified minority-serving institutions across the U.S. and Puerto Rico to help improve diversity in science and health care.
Save the Date: PGY Research & Education Day
Stay up to date on this event by visiting its page here.
SAVE THE DATE
May 22, 2019 at the Bill Gatton Student Center
More details to follow about:
Registration
Agenda
Research Blitz
Poster Session
AJPH publishes New Perspectives to Advance Minority Health and Health Disparities Research
"The American Journal of Public Health special issue New Perspectives to Advance Minority Health and Health Disparities Research is the culmination of a 2-year NIMHD-led transdisciplinary science visioning process that bridged scientific disciplines to develop a coordinated research vision.
Recent Faculty Publication: Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis
Abstract
Heparin-binding EGF-like growth factor (HB-EGF) is a representative EGF family member that interacts with EGFR under diverse stress environment. Previously, we reported that the HB-EGF-targeting using antisense oligonucleotide (ASO) effectively suppressed an aortic aneurysm in the vessel wall and circulatory lipid levels. In this study, we further examined the effects of the HB-EGF ASO administration on the development of hyperlipidemia-associated atherosclerosis using an atherogenic mouse model.
METHODS AND RESULTS:
Clinical Trial Gives UK Pathologist New Hope
As a longtime pathologist at the University of Kentucky, Dr. Charles Lutz is no stranger to cancer.
Lutz has spent much of his career in the lab, helping patients behind the scenes. At the UK Markey Cancer Center, he works in molecular diagnosis and HLA tissue typing in bone marrow transplantation for leukemia and other cancers. He also helps match patients in end-stage organ failure with an appropriate solid organ transplant for the UK Transplant Center.